Autoinflammatory syndromes with a dermatological perspective

Journal of Dermatology

Volumn 34, Issue 9, 2007, Pages 601-618

  Kanazawa, Nobuo ^a   Furukawa, Fukumi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoinflammatory syndromes; Gene mutations; Hereditary periodic fever syndromes; Innate immunity; NOD LRR proteins

Indexed keywords

AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; CROHN DISEASE; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INNATE IMMUNITY; MUCKLE WELLS SYNDROME; PSORIATIC ARTHRITIS; RECURRENT FEVER; REVIEW; SARCOIDOSIS;

ANIMALS; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; FAMILIAL MEDITERRANEAN FEVER; HUMANS; INFLAMMATION; MUTATION; RARE DISEASES; SKIN DISEASES; SYNDROME;

EID: 34548165205     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00342.x     Document Type: Review

References (150)

1. McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999 97:133 144.
2. Galon J, Aksentijevich I, McDermott MF, O'shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 2000 12:479 486.
3. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001 345:1748 1757.
4. Gattorno M, Martini A. Inherited autoinflammatory syndromes: an expanding new group of chronic inflammatory diseases. Clin Exp Rheumatol 2005 23:133 136.
5. Aksentijevich I, Nowak M, Mallah M et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002 46:3340 3348.
6. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003 15:61 69.
7. Galeazzi M, Gasbarrini G, Ghirardello A et al. Autoinflammatory syndromes. Clin Exp Rheumatol 2006 24:S79 S85.
8. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998 351:659 664.
9. Ida H, Eguchi K. Hereditary periodic fever syndromes in Japan. Intern Med 2005 44:177 178.
10. Barzilai A, Langevitz P, Goldberg I et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 2000 42:791 795.
11. Glikson M, Galun E, Schlesinger M et al. Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 1986 16:536 539.
12. Ozdogan H, Arisoy N, Kasapcapur O et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997 24:323 327.
13. Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr 2003 143:658 661.
14. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997 17:25 31.
15. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely cause familial Mediterranean fever. Cell 1997 90:797 807.
16. Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis-phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003 16:431 434.
17. Richards N, Schaner P, Diaz A et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001 276:39320 39329.
18. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003 302:575 580.
19. Chae JJ, Komarow H, Cheng J et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003 11:591 604.
20. Yu JW, Wu J, Zhang Z et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappa B, via ASC oligomerization. Cell Death Differ 2006 13:236 249.
21. Chae JJ, Wood G, Masters SL et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006 103:9982 9987.
22. Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K et al. E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 2004 79:235 237.
23. Milledge J, Shaw PJ, Mansour A et al. Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood 2002 100:774 777.
24. Van der Meer JW, Vossen JM, Radl J et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1984 1:1087 1090.
25. Drenth JP, Boom BW, Toonstra J, van der Meer JW. Cutaneous manifestations and histologic findings in the hyperommunoglobulinemia D syndrome. Arch Dermatol 1994 130:59 65.
26. Haraldsson A, Weemaes CM, De Boer AW, Bakkeren JA, Stoelinga GB. Immunological studies in the hyper-immunoglobulin D syndrome. J Clin Immunol 1992 12:424 428.
27. Miyagawa S, Kitamura W, Morita K, Saishin M, Shirai T. Association of hyperimmunoglobulinemia D syndrome with erythema elevatum diutinum. Br J Dermatol 1993 128:572 574.
28. Houten SM, Kuis W, Duran M et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinemia D and periodic fever syndrome. Nat Genet 1999 22:175 177.
29. Drenth JP, Cuisset L, Grateau G et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 1999 22:178 181.
30. Goldstein JL. Brown MS. Regulation of the mevalonate pathway. Nature 1990 343:425 430.
31. Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L. Mevalonic aciduria-an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Eng J Med 1986 314:1610 1614.
32. Cuisset L, Drenth JP, Simon A et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 2001 9:260 266.
33. Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 2002 11:3115 3124.
34. Frenkel J, Rijkers GT, Mandey SH et al. Lack of isoprenoid products raises ex vivo interleukin-1b secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2002 46:2794 2803.
35. Simon A, Drewe E, van der Meer JW et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 2004 75:476 483.
36. Gertz MA, Petitt RM, Perrault J, Kyle RA. Autosomal dominant familial Mediterranean fever-like syndrome with amyloidosis. Mayo Clin Proc 1987 62:1095 1100.
37. McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc 1997 72:806 817.
38. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 2000 136:1487 1494.
39. Lamprecht P, Moosig F, Adam-Klages S et al. Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 2004 63:1518 1520.
40. Ida H, Kawasaki E, Miyashita T et al. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology 2004 43:1292 1299.
41. Ida H, Aramaki T, Arima K, Origuchi T, Kawakami A, Eguchi K. Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis. Rheumatology 2006 45:1171 1173.
42. Kallinich T, Haffner D, Rudolph B et al. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis. Ann Rheum Dis 2006 65:958 960.
43. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med 2000 343:1044 1045.
44. Aganna E, Hammond L, Hawkins PN et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003 48:2632 2644.
45. Huggins ML, Radford PM, Mcintosh RS et al. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum 2004 50:2651 2659.
46. Rebelo SL, Bainbridge SE, Amel-Kashipaz MR et al. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum 2006 54:2674 2687.
47. Lobito AA, Kimberley FC, Muppidi JR et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in the TNFR1-associated periodic fever syndrome (TRAPS). Blood 2006 108:1320 1327.
48. Simon A, Bodar EJ, van der Hilst JC et al. Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med 2004 117:208 210.
49. Doeglas HMG, Bleumink E. Familial cold urticaria: clinical findings. Arch Dermatol 1974 110:382 388.
50. Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: A new heredo-family syndrome. Q J Med 1962 31:235 248.
51. Prieur AM, Griscelli C, Lampert F et al. A chronic, infantile, neurological, cutaneous and auticular (CINCA) syndrome: a specific entity analysed in 30 patients. Scand J Rheumatol 1987 66S:57 68.
52. Huttenlocher A, Frieden IJ, Emery H. Neonatal onset multisystem inflammatory disease. J Rheumatol 1995 22:1171 1173.
53. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutations of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001 29:301 305.
54. Feldmann J, Prieur AM, Quartier P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002 71:198 203.
55. Neben B, Callebaut I, Prieur AM et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004 103:2809 2815.
56. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta. Mol Cell 2002 10:417 426.
57. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1-beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004 20:319 325.
58. Sutterwala FS, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006 24:317 327.
59. Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004 364:1779 1785.
60. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to Anakinra. Arthritis Rheum 2004 50:607 612.
61. Hawkins PN, Bybee A, Aganna E, McDermott MF. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis Rheum 2004 50:2708 2709.
62. Kanneganti TD, Oezoeren N, Body-Malapel M et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006 440:233 236.
63. Saito M, Fujisawa A, Nishikomori R et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005 52:3579 3585.
64. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997 72:611 615.
65. Padeh S, Brezniak N, Zemer D et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999 135:98 101.
66. Wise CA, Gillum JD, Seidman CE et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002 11:961 969.
67. Cote JF, Chung PL, Theberge JF et al. PSTPIP is a substrate of PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. J Biol Chem 2002 277:2973 2986.
68. Mansfield E, Chae JJ, Komarow HD et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 2001 98:851 859.
69. Shoham NG, Centola M, Mansfield E et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Nat Acad Sci USA 2003 100:13501 13506.
70. McDermott MF. A common pathway in periodic fever syndromes. Trends Immunol 2004 25:457 460.
71. Jacobs JC, Goetzl EJ. "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum. Pediatrics 1975 56:570 578.
72. Hetherington S. Sarcoidosis in young children. Am J Dis Child 1982 136:13 15.
73. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985 107:689 693.
74. Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y. Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Dermatol 2004 122:851 852.
75. Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol 2004 51:606 624.
76. Kanazawa N, Okafuji I, Kambe N et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappa B activation: common genetic etiology with Blau syndrome. Blood 2005 105:1195 1197.
77. Miceli-Richard C, Lesage S, Rybojad M et al. CARD15 mutations in Blau syndrome. Nat Genet 2001 29:19 20.
78. Kambe N, Nishikomori R, Kanazawa N. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. J Dermatol Sci 2005 39:71 80.
79. Rose CD, Wouters CH, Meiorin S et al. Pediatric Granulomatous Arthritis: an international registry. Arthritis Rheum 2006 54:3337 3344.
80. McDonald C, Inohara N, Nunez G. Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem 2005 280:20177 20180.
81. Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic "symmetrical" osteomyelitis. Ann Radiol 1972 15:329 342.
82. Majeed HA, Kalaawi M, Mohanty D et al. Congenital Dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 1989 115:730 734.
83. Ferguson PJ, Bing X, Vasef MA et al. A missense mutation in pstpip2 in associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006 38:41 47.
84. Grosse J, Chitu V, Marquardt A et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood 2006 107:3350 3358.
85. Chitu V, Pixley FJ, Macaluso F et al. The PCH family member MAYP/PSTPIP2 directly regulates F-actin bundling and enhances filopodia formation and motility in macrophages. Mol Biol Cell 2005 16:2947 2959.
86. Ferguson PJ, Chen S, Tayeh MK et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome). J Med Genet 2005 42:551 557.
87. Al-Mosawi ZS, Al-Saad KK, Ijadi-Maghsoodi R, El-Shanti HI, Ferguson PJ. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum 2007 56:960 964.
88. Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 2001 27:121 124.
89. Golla A, Jansson A, Ramser J et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002 10:217 221.
90. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003 87:1175 1183.
91. Verity DH, Vaughan RW, Marr JE et al. Behçet's disease, The Silk Road and HLA-B51: historical and geographical perspective. Tissue Antigens 1999 54:213 220.
92. Fietta P. Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol 2005 23:S96 S105.
93. Touitou I, Magne X, Molinari N et al. MEFV mutations in Behçet's disease. Hum Mutat 2000 16:271 272.
94. Livneh A, Aksentijevich I, Langevitz P et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet 2001 9:191 196.
95. Amoura Z, Dode C, Hue S et al. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis Rheum 2005 52:608 611.
96. Kone-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I. Autoinflammatory gene mutations in Behçet's disease. Ann Rheum Dis 2007 66:832 834.
97. Uyar FA, Saruhan-Direskeneli G, Gul A. Common Crohn's disease-predisposing variants of the CARD15/NOD2 gene are not associated with Behçet's disease in Turkey. Clin Exp Rheumatol 2004 22:S50 S52.
98. Espinosa G, Arostegui JI, Plaza S et al. Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 2005 23:S3 S7.
99. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411:599 603.
100. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001 411:603 606.
101. Chamaillard M, Philpott D, Girardin SE et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003 100:3455 3460.
102. Behr MA, Semret M, Poon A, Schurr E. Crohn's disease, mycobacteria, and NOD2. Lancet Infect Dis 2004 4:136 137.
103. Wehkamp J, Stange EF. NOD2 mutation and mice: no Crohn's disease but many lessons to learn. Trends Mol Med 2005 11:307 309.
104. Eckmann L, Karin M. NOD2 and Crohn's disease: loss or gain of function? Immunity 2005 22:661 667.
105. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006 25:473 485.
106. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999 354:120 123.
107. Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J 2003 22:748 754.
108. Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 2003 136:933 935.
109. Ho LP, Merlin F, Gaber K, Davies RJ, McMichael AJ, Hugot JP. CARD 15 gene mutations in sarcoidosis. Thorax 2005 60:354 355.
110. Milman N, Nielsen OH, Hviid TV, Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 2007 74:76 79.
111. Gazouli M, Koundourakis A, Ikonomopoulos J et al. CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 23:23 29.
112. Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002 123:86 91.
113. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002 47:469 472.
114. Tanabe T, Ishige I, Suzuki Y et al. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta 2006 1762:794 801.
115. McGovern DP, Hysi P, Ahmad T et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005 14:1245 1250.
116. Ozen SC, Dagli U, Kilic MY et al. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. J Gastroenterol 2006 41:304 310.
117. Tremelling M, Hancock L, Bredin F, Sharpstone D, Bingham SA, Parkes M. Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel. Inflamm Bowel Dis 2006 12:967 971.
118. Van Limbergen J, Russell RK, Nimmo ER et al. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe. Inflamm Bowel Dis 2007 13:882 889.
119. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990 85:962 963.
120. Nair RP, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997 6:1349 1356.
121. Nair RP, Stuart P, Ogura Y et al. Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol 2001 117:1671 1672.
122. Borgiani P, Vallo L, D'Apice MR et al. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol 2002 12:540 542.
123. Young C, Allen MH, Cuthbert A et al. A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Exp Dermatol 2003 12:506 509.
124. Plant D, Lear J, Marsland A, Worthington J, Griffiths CE. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis. Br J Dermatol 2004 151:675 678.
125. Karason A, Gudjonsson JE, Upmanyu R et al. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 2003 72:125 131.
126. Rahmen P, Bartlett S, Siannis F et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 2003 73:677 681.
127. Giardina E, Novelli G, Costanzo A et al. Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J Invest Dermatol 2004 122:1106 1107.
128. Lascorz J, Burkhardt H, Huffmeier U et al. Lack of genetic association of the three more common polymorphisms of CARD15 with psoriatic arthritis and psoriasis in a German cohort. Ann Rheum Dis 2005 64:951 954.
129. Ho P, Bruce IN, Silman A et al. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 2005 52:3596 3602.
130. Jenisch S, Hampe J, Elder JT et al. CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association. Arch Dermatol Res 2006 297:409 411.
131. Cavanaugh J. NOD2: ethnic and geographic differences. World J Gastroenterol 2006 12:3673 3677.
132. Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003 111:813 817.
133. Weidinger S, Klopp N, Rummler L et al. Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy 2005 35:866 872.
134. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004 5:800 808.
135. Hysi P, Kabesch M, Moffatt MF et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005 14:935 941.
136. Weidinger S, Klopp N, Rummler L et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 2005 116:177 184.
137. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007 369:767 778.
138. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005 201:1479 1486.
139. Fishman D, Faulds G, Jeffery R. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998 102:1369 1376.
140. Donn R, Alourfi Z, De Benedetti F et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002 46:2402 2409.
141. De Benedetti F, Meazza C, Vivarelli M et al. Functional and prognostic relevance of the-173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003 48:1398 1407.
142. Akimoto R, Yoshida M, Matsuda R, Miyasaka K, Itoh M. Schnitzler's syndrome with IgG kappa gammopathy. J Dermatol 2002 29:735 738.
143. Martinez-Taboada VM, Fontalba A, Blanco R, Fernandez-Luna JL. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 2005 52:2226 2227.
144. De Koning HD, Bodar EJ, Simon A, van der Hilst JC, Netea MG, van der Meer JW. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006 65:542 544.
145. Dalle S, Balme B, Sebban C, Pariset C, Berger F, Thomas L. Schnitzler syndrome associated with systemic marginal zone B-cell lymphoma. Br J Dermatol 2006 155:827 829.
146. Ramadan KM, Eswedi HA, El-Agnaf MR. Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br J Dermatol 2007 156:1072 1074.
147. Ting JP, Kastner DL, Hoffman HM. CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 2006 6:183 195.
148. Inohara N, Chamaillard M, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005 74:355 383.
149. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005 26:447 454.
150. Jin Y, Mailloux CM, Gowan K et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Eng J Med 2007 356:1216 1225.